Who made the gains in May? Goldies hog top spot on the podium
DTR takes top spot for biggest monthly stock gain
Resource Mining Corp nabs honourable mention
With gold prices near record highs and in the vicinity of US$3300/oz, gold explorers and miners continue to crowd the leaderboards for the ASX's top resource stock gainers of May.
The biggest winner for the month was goldie Dateline Resources (ASX:DTR), up a frankly quite ridiculous 978%. Worth less than $10 million only a month or two ago, the owner of the 1.1Mo Colosseum gold project in California. More on that below.
It was followed by Resource Mining Corporation (ASX:RMI) and Locksley Resources (ASX:LKY) up 460% and 321% respectively.
The Donald likes Dateline
Much of Dateline's growth can be put down to a shoutout from US President Donald Trump on his Truth Social platform that got investors excited.
DTR owns the 1.1Moz Colosseum gold project, where Trump highlighted the company's rare earths potential, sitting just a few kms from the Mountain Pass mine.
The company also released an updated scoping study last week based around a gold price estimate lifted from US$2200/oz in a study compiled in October last year to US$2900/oz.
With annual gold production unchanged at 71,000ozpa, that would lift net revenue before tax by 208%from US$398m to US$827m and ups the project's IRR from 31% to 61%.
Before tax discounted cashflow would rise 234% to US$550m. Also this week DTR reported possible hidden extensions of gold breccia pipes at the project, pointing to the potential for hidden gold zones beyond historical workings.
There's a nice upside emerging, particularly since all 641 historic drill holes targeted only the breccia pipes with surface exposure and large areas of the property remain effectively untested.
Most popular commodities in May:
Here are the top 50 ASX resources stocks for the month of May
Scroll or swipe to reveal table. Click headings to sort.
Code Description Last %Mth MktCap
XTC XTC Lithium Limited 0.2 19900% $17,528,272
DTR Dateline Resources 0.097 978% $262,956,021
RMI Resource Mining Corp 0.028 460% $21,299,147
LKY Locksley Resources 0.08 321% $9,680,000
SMM Somerset Minerals 0.024 140% $9,722,874
PUA Peak Minerals Ltd 0.021 133% $56,146,426
OCN Oceana lithium 0.059 119% $7,837,294
RML Resolution Minerals 0.017 113% $7,361,016
PEK Peak Rare Earths Ltd 0.255 108% $89,789,736
HRE Heavy Rare Earths 0.041 105% $8,529,389
FRS Forrestania Resources 0.079 103% $25,772,734
HIO Hawsons Iron Ltd 0.026 100% $25,412,534
LLI Loyal Lithium Ltd 0.13 97% $13,095,298
NWC New World Resources 0.047 96% $168,210,882
TMG Trigg Minerals Ltd 0.081 88% $75,757,331
MM1 Midas Minerals 0.28 87% $38,837,399
VTM Victory Metals Ltd 0.88 85% $101,837,524
SPD Southern Palladium 0.415 84% $35,470,500
BTM Breakthrough Minerals 0.125 84% $5,264,545
VRL Verity Resources 0.029 81% $7,742,283
YAR Yari Minerals Ltd 0.009 80% $4,992,403
MEG Megado Minerals Ltd 0.014 75% $5,875,566
CDT Castle Minerals 0.1 72% $11,020,909
CDR Codrus Minerals Ltd 0.034 70% $6,822,235
TAS Tasman Resources Ltd 0.025 67% $3,314,567
BMR Ballymore Resources 0.165 65% $27,393,241
FML Focus Minerals Ltd 0.385 60% $101,728,319
ANX Anax Metals Ltd 0.008 60% $7,062,461
JAL Jameson Resources 0.04 60% $23,207,866
MGU Magnum Mining & Exp 0.008 60% $7,851,556
WTM Waratah Minerals Ltd 0.32 60% $74,723,925
STK Strickland Metals 0.145 56% $316,730,372
FG1 Flynn Gold 0.031 55% $11,348,178
VRX VRX Silica Ltd 0.062 55% $47,080,107
MTM MTM Critical Metals 0.37 54% $151,363,716
BGD Barton Gold Holdings 0.735 52% $158,720,391
AYM Australia United Min 0.003 50% $5,527,732
CMD Cassius Mining Ltd 0.024 50% $16,937,640
CTN Catalina Resources 0.003 50% $8,491,067
OB1 Orbminco Limited 0.0015 50% $4,795,136
RLL Rapid Lithium Ltd 0.003 50% $3,734,834
SER Strategic Energy 0.009 50% $6,039,300
SNX Sierra Nevada Gold 0.027 50% $4,281,137
BKT Black Rock Mining 0.03 50% $44,083,197
NNL Nordicresourcesltd 0.085 49% $14,457,374
TNC True North Copper 0.325 48% $39,010,095
WCN White Cliff Min Ltd 0.028 47% $60,408,040
NMT Neometals Ltd 0.093 45% $69,248,258
CLE Cyclone Metals 0.056 44% $72,396,276
DES Desoto Resources 0.15 43% $27,002,546
Small Cap Standouts
Resource Mining Corporation (ASX:RMI)
Exploration at the company's Mpanda copper-gold project has been the catalyst for its gains in May, with the company reporting impressive gold and copper grades from rock samples up to 36.7g/t gold and 11.89g/t copper from Kabungu and 13.58% copper and 3.24g/t gold from Stalike.
Ten prospects make up the Mpanda Project and RMI believes results to date provide an indicator of the presence of an extensive mineralised system.
There have been 16 rock chip samples from small-scale mines gathered within RMC's tenements with five samples exceeding 11g/t gold and two exceeding 10% copper from the Kabungu prospect.
Last month the company also reported strong support for a $2m placement at 2.1c per share to accelerate drilling.
Plus, looking forward, RMI is also assessing near-term production opportunities at Stalike and Kabungu by utilising nearby existing third-party processing infrastructure.
Locksley Resources (ASX:LKY)
Locksley saw some great gains in May, following a $1.47m placement at 4c per share to fund an upcoming exploration campaign, including drilling, at the Mojave antimony and rare earths project in California.
While waiting for Bureau of Land Management approvals to be granted, the company's exploration team will conduct follow-up mapping and rock chip sampling across high-priority antimony, REE, polymetallic and copper targets.
Drilling is expected to begin in the September quarter, and will focus on the El Campo prospect where six holes will be drilled to test TREO of up to 12.1% and the Desert Antimony Mine, with three holes testing high-grade antimony mineralisation of up to 46%.
Notably, Mojave is immediately adjacent to MP Materials' high-grade Mountain Pass mine and processing facility, which is the only active REE processor in the US and produces ~15% of global REE supply.
REEs and antimony are designated as critical minerals by the US government with the former – particularly magnet REEs – used to manufacture permanent rare earth magnets that are used in electric vehicle motors and wind turbines.
Rock chips at Mojave have returned grades of up to 17% while sampling returned high-grade results of between 3.74% and 9.49% total rare earth oxides within a six-metre wide mineralised zone at the El Campo prospect.
Somerset Minerals (ASX:SMM)
Up 140% for May was Somerset Metals, who completed its acquisition of the Coppermine copper-silver project in Canada, which is adjacent to White Cliff Minerals (ASX:WCN) Rae project.
Drilling at the Coronation prospect also kicked off this month, targeting large coincident geophysical and geochemical anomalies only 7km from WCN's Danvers prospect - which recently reported 58m at 3.08% copper from 52m.
So far, widespread copper mineralisation has been identified, with assays expected in the next 2-4 weeks.
Somerset is particularly confident of strong results since its extensive land package hosts the strike extensions to White Cliff's primary Vision, Stark, Thor, and Rocket districts, and most of the ground surrounding the Danvers prospect.
Peak Minerals (ASX:PUA)
PUA saw a gain of 133% for the month, thanks in part to intersecting heavy minerals (HM) across a strike length of 28km at the Minta rutile project in Cameroon.
The company said the results of up to 3.1m at 8.4% HM, 6.8m at 2.8%, 3.5m at 5.0% and 6.3m at 2.4% from an additional 29 holes of reconnaissance exploration auger drilling confirm the project's significant scale.
Not to mention, the initial intercepts are adjacent to the discovery hole of 4m at 1.57% HM which included 4m at 1.05% rutile.
'This second batch of results from the drilling program at the Minta Rutile Project in Cameroon continues to confirm the extensive scale and consistency of heavy mineral mineralisation across the project area,' Peak Minerals CEO Casper Adson said.
'With the Minta Project spanning over 7000km2 and this initial drilling phase covering approximately 50% of the total project area, these findings underscore the substantial potential of this emerging rutile province.
'These results reinforce the scale of the Minta Project, underscoring its potential as a significant new source of rutile and potentially a globally significant rutile province.'
We wonder whether there is a case of mistaken identity here. Peak's big lift came around the same time African rare earths developer Peak Rare Earths (ASX:PEK) was taken out at a massive premium for $150.5m by Shenghe Resources.
Oceana Lithium (ASX:OCN)
Up 119% for May, OCN holds the Napperby project in NT which covers around ~650km2 within within the Northern Arunta pegmatite province.
It also has the Solonópole project in Brazil where an exploration licence extension is pending for the promising Nera prospect.
This month the company announced commitments to raise $667,000 towards progressing the projects, and to identify and assess new complimentary project opportunities.
'Securing additional funds ensures Oceana is well placed to progress the company's existing assets in Brazil and Australia, as well as continue to assess new project opportunities,' non-executive chairman Martin Helean said.
'We look forward to providing updates on exploration activities across our portfolio in the near term.
'We thank our existing shareholders for their ongoing support, and are pleased to welcome new shareholders to the company.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

News.com.au
28 minutes ago
- News.com.au
Alaska: a source of Russian imperial nostalgia
Alaska, the US state that will host the meeting between Vladimir Putin and Donald Trump on Friday, is a source of imperial nostalgia and often less-than-serious territorial claims in Russia. The territory that Russia sold to the United States in 1867 is now a symbol of the entwined history of the countries, whose relations have been severely damaged since Russia launched its offensive in Ukraine in 2022. To some experts, the summit in Alaska evoked memories of the thaw between the Soviet Union and the United States during the Cold War. "It's a classically orchestrated summit, like in the era of detente," Russian political scientist Fyodor Lukyanov said on Telegram. "Its symbolic significance is the absence of intermediaries: the powers, so to speak, decide for themselves," he added, saying that China is "not close" to Alaska and that Europe is "as far away as possible". - Fur trading hub - But beyond being a unique meeting place, Alaska also fuels Russian memories of the Tsarist empire, the historic predecessor of the Soviet Union. "For Russia, Alaska symbolises the peak of an expansion," Alexander Baunov, senior fellow at the Carnegie Russia Eurasia Center, said on the centre's website. It was "when the Russian continental empire had, for the only time, succeeded in crossing an ocean like the European empires", Baunov said. A Russian colony since the 18th century, Alaska was eventually sold to the United States for $7.2 million in 1867 by Tsar Alexander II. The remote territory was economically very difficult for the Russians to exploit and at the time its sale was welcomed by the Imperial Court as the country was struggling economically. But the transaction later came to be seen as a regrettable bargain after what formerly was a fur trading hub turned out to house crucial natural resources: gold and oil. - 'Our bears' - In recent years, the price at which Alaska was sold, considered by some to be ridiculously low, and the legal validity of the transaction have become regularly recurring debates in Russia. In July 2022, in the midst of patriotic fervour in Russia and as tensions soared between Moscow and Washington following the offensive against Ukraine, the Alaska issue resurfaced. The speaker of the Duma, the lower house of the Russian Parliament, Vyacheslav Volodin, spoke of "lands to be returned", describing Alaska as a "disputed territory". Russia's authorities are apparently not interested in reclaiming it. In 2014, Vladimir Putin, asked by a pensioner about the possibility, replied: "My dear, why do you need Alaska?" adding the territory was "too cold". Still, the idea of reclaiming Alaska is an endless source of memes widely circulating on Russian social media. One of the most famous claims that "our soul" suffered from the loss of Alaska because "it's where our bears live". The recapture of Alaska is even mentioned in a 1990s hit by a rock band Putin likes, Lyube, with the lyrics: "Stop messing around, America... And give back our Alaskan lands."

ABC News
an hour ago
- ABC News
NBA approves American record sale of Boston Celtics to private equity mogul Bill Chisholm
The NBA has unanimously approved the sale of the Boston Celtics to a group led by private equity mogul Bill Chisholm, a deal that values the franchise at $9.31 billion (US$6.1 billion). The league said the transaction is expected to close soon. When it does, Chisholm will take ownership of at least 51 per cent of the team, with full control coming by 2028 at a price that could bring the total value to $11.15 billion (US$7.3 billion). That's the largest price ever paid for an American professional sports team, though Los Angeles Dodgers owner Mark Walter has agreed to buy a controlling share of the Lakers in a deal that would place the value of the entire franchise at $15.27 billion (US$10 billion). It's not clear how much Walter would own; current owner Jeanie Buss is expected to retain at least 15 per cent of the team. The previous record for a US sports franchise was the US$6.05 billion paid for the NFL's Washington Commanders in 2023. The record price for an NBA team was the US$4 billion mortgage firm owner Mat Ishbia paid for the Phoenix Suns in 2023. A Massachusetts native and graduate of Dartmouth College and Penn's Wharton School of business, Chisholm is the managing partner of California-based Symphony Technology Group. The new ownership group also includes Boston businessmen Rob Hale, who is a current Celtics shareholder, and Bruce Beal Jr. Wyc Grousbeck led the ownership group that bought the team in 2002 for US$360 million and presided over NBA championships in 2008 and 2024. The franchise's 18 NBA titles is a record. Chisholm outbid at least two other groups, one led by previous Celtics minority partner Steve Pagliuca. Pagliuca has since announced plans to but the WNBA's Connecticut Sun for US$325 million and move them to Boston, but the women's league has baulked at the deal. AP

The Australian
2 hours ago
- The Australian
Argenica brain drug paces for FDA clearance
FDA provides clear path for Argenica to lift clinical hold on its ARG-007 stroke drug Further clarification on safety of dose in humans and three additional in vitro lab studies requested Company confident studies are straightforward and can be completed quickly Special Report: Argenica Therapeutics now has a clear path forward to clear the clinical hold currently in place on its investigational new drug application that will enable clinical trials for its lead drug ARG-007. In its full letter, the US Food and Drug Administration (FDA) requested additional information to provide assurance that proposed dosing for a US trial of ARG-007 in acute ischaemic stroke can be achieved safely in humans. The FDA has also requested that Argenica Therapeutics (ASX:AGN) conduct three additional in vitro cell culture studies with clinical research organisations to address identified gaps in data. AGN plans to use safety data from its Phase 2 acute ischaemic stroke trial, which will be available in September, as part of its response to the FDA's request for safety assurance. It adds that three additional studies are small ones that can be completed quickly and build on existing data it has already generated. 'We are pleased to have received the clarification from the FDA as to the additional information required to progress the IND application,' managing director Dr Liz Dallimore said. 'Importantly from a timing and cost perspective, the requested additional in vitro assays are standard assays which are straightforward and efficient to perform. 'Argenica will work with the FDA to ensure the proposed approach to providing the additional information is adequate to lift the clinical hold.' Preventing brain injury During acute neurological events such as stroke, traumatic brain injury (TBI), and hypoxic brain damage, around 1.9 million brain cells die for every minute that blood flow is halted. AGN's ARG-007 is a synthetic peptide designed to protect brain cells from dying in the critical minutes and hours by protecting brain tissue during and after these events. The company noted it was targeting acute ischaemic stroke as many patients that experienced it had a thrombectomy, where a radiologist inserts a catheter through the wrist or groin and guides it up into the brain to physically remove a clot. However, this process has the risk of reperfusion injury, which occurs when blood flow rapidly returns to previously oxygen-deprived brain tissue after a clot is removed and potentially causes additional damage. Dosing of patients in a double-blinded, randomised, placebo-controlled Phase 2 trial of ARG-007 in acute ischaemic stroke patients was completed in April. This involved 92 patients presenting to eight emergency departments around Australia with data-read out due in September with safety the main endpoint. The secondary endpoint for the trial will examine efficacy, with a brain scan taken 48 hours post administration of either the placebo or ARG-007. ARG-007 would be the first neuroprotective drug on the global market if approved, tapping into a large addressable global market for stroke and potentially other indications. The global stroke management market was valued at $36.1 billion in 2022, and is projected to reach $74 bn by 2032, driven by several factors including a growing ageing population. There are more than 45,000 strokes annually in Australia and 795,000 in the US – the world's largest healthcare markets. This article was developed in collaboration with Argenica Therapeutics, a Stockhead advertiser at the time of publishing. This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.